Annual EBITDA
-$221.91 M
-$4.24 M-1.95%
December 31, 2024
Summary
- As of March 10, 2025, VERV annual EBITDA is -$221.91 million, with the most recent change of -$4.24 million (-1.95%) on December 31, 2024.
- During the last 3 years, VERV annual EBITDA has fallen by -$136.38 million (-159.44%).
- VERV annual EBITDA is now -1539.38% below its all-time high of -$13.54 million, reached on December 31, 2019.
Performance
VERV EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$54.37 M
+$789.00 K+1.43%
December 1, 2024
Summary
- As of March 10, 2025, VERV quarterly EBITDA is -$54.37 million, with the most recent change of +$789.00 thousand (+1.43%) on December 1, 2024.
- Over the past year, VERV quarterly EBITDA has stayed the same.
- VERV quarterly EBITDA is now -749.48% below its all-time high of -$6.40 million, reached on June 30, 2020.
Performance
VERV Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$221.91 M
-$1.94 M-0.88%
December 1, 2024
Summary
- As of March 10, 2025, VERV TTM EBITDA is -$221.91 million, with the most recent change of -$1.94 million (-0.88%) on December 1, 2024.
- Over the past year, VERV TTM EBITDA has stayed the same.
- VERV TTM EBITDA is now -2980.33% below its all-time high of -$7.20 million, reached on March 31, 2020.
Performance
VERV TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
VERV EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -1.9% | 0.0% | 0.0% |
| 3 y3 years | -159.4% | -6.9% | -4.7% |
| 5 y5 years | -1539.4% | -6.9% | -4.7% |
VERV EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -159.4% | at low | -73.1% | +5.0% | -159.4% | at low |
| 5 y | 5-year | -1539.4% | at low | -749.5% | +5.0% | -2980.3% | at low |
| alltime | all time | -1539.4% | at low | -749.5% | +5.0% | -2980.3% | at low |
Verve Therapeutics EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | -$221.91 M(+1.9%) | - | - |
| Dec 2024 | - | -$54.37 M(-1.4%) | -$221.91 M(+0.9%) |
| Sep 2024 | - | -$55.16 M(-3.5%) | -$219.97 M(+2.0%) |
| Jun 2024 | - | -$57.17 M(+3.5%) | -$215.68 M(-0.0%) |
| Mar 2024 | - | -$55.21 M(+5.3%) | -$215.75 M(-0.9%) |
| Dec 2023 | -$217.67 M(+33.6%) | -$52.43 M(+3.1%) | -$217.67 M(+2.7%) |
| Sep 2023 | - | -$50.86 M(-11.2%) | -$212.02 M(+3.8%) |
| Jun 2023 | - | -$57.25 M(+0.2%) | -$204.31 M(+8.3%) |
| Mar 2023 | - | -$57.13 M(+22.1%) | -$188.60 M(+15.8%) |
| Dec 2022 | -$162.88 M | -$46.78 M(+8.4%) | -$162.88 M(+9.9%) |
| Sep 2022 | - | -$43.14 M(+3.8%) | -$148.17 M(+15.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | -$41.54 M(+32.3%) | -$128.11 M(+24.2%) |
| Mar 2022 | - | -$31.41 M(-2.0%) | -$103.18 M(+20.6%) |
| Dec 2021 | -$85.53 M(+117.6%) | -$32.07 M(+38.9%) | -$85.53 M(+20.8%) |
| Sep 2021 | - | -$23.09 M(+39.0%) | -$70.81 M(+26.3%) |
| Jun 2021 | - | -$16.61 M(+20.6%) | -$56.07 M(+22.3%) |
| Mar 2021 | - | -$13.77 M(-20.6%) | -$45.86 M(+16.7%) |
| Dec 2020 | -$39.30 M(+190.3%) | - | - |
| Dec 2020 | - | -$17.35 M(+107.8%) | -$39.30 M(+79.0%) |
| Sep 2020 | - | -$8.35 M(+30.4%) | -$21.95 M(+61.4%) |
| Jun 2020 | - | -$6.40 M(-11.2%) | -$13.60 M(+88.8%) |
| Mar 2020 | - | -$7.20 M | -$7.20 M |
| Dec 2019 | -$13.54 M | - | - |
FAQ
- What is Verve Therapeutics annual EBITDA?
- What is the all time high annual EBITDA for Verve Therapeutics?
- What is Verve Therapeutics annual EBITDA year-on-year change?
- What is Verve Therapeutics quarterly EBITDA?
- What is the all time high quarterly EBITDA for Verve Therapeutics?
- What is Verve Therapeutics quarterly EBITDA year-on-year change?
- What is Verve Therapeutics TTM EBITDA?
- What is the all time high TTM EBITDA for Verve Therapeutics?
- What is Verve Therapeutics TTM EBITDA year-on-year change?
What is Verve Therapeutics annual EBITDA?
The current annual EBITDA of VERV is -$221.91 M
What is the all time high annual EBITDA for Verve Therapeutics?
Verve Therapeutics all-time high annual EBITDA is -$13.54 M
What is Verve Therapeutics annual EBITDA year-on-year change?
Over the past year, VERV annual EBITDA has changed by -$4.24 M (-1.95%)
What is Verve Therapeutics quarterly EBITDA?
The current quarterly EBITDA of VERV is -$54.37 M
What is the all time high quarterly EBITDA for Verve Therapeutics?
Verve Therapeutics all-time high quarterly EBITDA is -$6.40 M
What is Verve Therapeutics quarterly EBITDA year-on-year change?
Over the past year, VERV quarterly EBITDA has changed by $0.00 (0.00%)
What is Verve Therapeutics TTM EBITDA?
The current TTM EBITDA of VERV is -$221.91 M
What is the all time high TTM EBITDA for Verve Therapeutics?
Verve Therapeutics all-time high TTM EBITDA is -$7.20 M
What is Verve Therapeutics TTM EBITDA year-on-year change?
Over the past year, VERV TTM EBITDA has changed by $0.00 (0.00%)